US D2C telemed; lost branded Wegovy contract Jun 2025, pivoted to compounded
maturecompetitor
Public NYSE: HIMS. Consumer telemed for hair, skin, weight loss, mental health. Lost branded Wegovy partnership with Novo Nordisk Jun 2025 over compounding concerns. Profitable but volatile post-Novo break.